Fee-for-service hit discovery is backwards.
OpenBench offers a simple solution. We bear the cost of virtual screening, synthesis, and experimental confirmation, so that the first dollar our collaborators spend is on potent, developable hit series. This success-driven paradigm fosters rigor, accountability, and operational efficiency.
We construct hit criteria jointly with partners to ensure outcomes motivate further hit-to-lead pursuit. Once a deal is in place, our partners receive compounds in their labs in 2 months with validation soon to follow.
OpenBench’s technology uniquely enables this success-driven paradigm. We manage scientific risk by picking hits from massive virtual libraries >100x more efficiently than conventional methods. Screening and judiciously filtering billion-compound libraries ensures novelty and developability of hits—traits conventional solutions cannot promise.
To sign up for the OpenBench waitlist, please visit https://opnbnch.com
Company Details
- Employees
- 9
- Address
- San Francisco, Ca, Us
- su****@****nch.com
- Industry
- Biotechnology
- Website
- opnbnch.com
- Keywords
- hit discovery is backwards..
- HQ
- San Francisco, CA
Openbench Questions
Openbench's website is opnbnch.com
Openbench's LinkedIn profile is https://www.linkedin.com/company/openbench
Openbench has
9 employees.
View email and phone details for 9
employees at Openbench.
Openbench's industry is
Biotechnology
Openbench's top competitors are
Oric Pharmaceuticals Inc.,
Neomorph, Inc.,
Ora,
858 Therapeutics,
Xaira Therapeutics,
Nanome,
Onkure Therapeutics,
Tetrascience,
Poseida Therapeutics, Inc.,
Hexagon Bio.
Openbench's support email address is support@opnbnch.com
Openbench's categories are Biotechnology
